Karyopharm is seeking FDA approval via accelerated pathway, which is informing market expectations.

The entities involved

• FDA →
  • Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
  • A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56
• MarketBeat →

  American personal finance blog

  • Apple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Mon 17:22
  • MarketBeat aggregates data on IDT Corporation stock performance.Mon 17:15
• Nasdaq →

  American fully electronic stock exchange

  • Vanguard Short-Term Inflation-Protected Securities ETF is disclosing its holdings to the SEC and trading on the Nasdaq electronic stock exchange.Mon 16:28
  • The Securities and Exchange Commission (SEC) has issued a requirement regarding the disclosure of fund purchases.Mon 16:09

Related events

• FDA and Pfizer are seeking regulatory approval for their products.Aug 29
• Decoy Therapeutics is listed on the Nasdaq stock exchange and is currently seeking expedited regulatory approval via FDA pathways.Sep 22
• FDA approval enables commercial opportunity involving CBRE Group.Sep 17
• FDA approval clears the path for drug market entry, driving future regulatory focus for major pharmaceutical companies.Aug 18
• The FDA is monitoring drug industry practices and pricing, utilizing studies published by JAMA.Sep 10